Patents by Inventor Rongrong LONG

Rongrong LONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cytotoxin and conjugate, uses of same and preparation method therefor
    Patent number: 11207420
    Abstract: Provided is a method for modifying a chimeric antigen receptor-modified T cell (CAR-T cell). The method comprises expressing an SCFV-CDS TM-4-1BB-CD3? molecule in a T cell. The CAR-T cell prepared using the method can specifically recognize and bind to a tumor cell with elevated expression of a ROBO1 protein, and can be used to prevent and treat a corresponding tumor-related disease.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: December 28, 2021
    Assignee: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Jiaqiang Cai, Tongtong Xue, Shuai Song, Jing Wang, Qiang Tian, Liang Xiao, Hanwen Deng, Liping Liu, Zujian Tang, Hong Zeng, Rongrong Long, Hongmei Song, Qiang Zhang, Guoqing Zhong, Dengnian Liu, Haitao Huang, Ruibin Hu, Lichun Wang, Jingyi Wang
  • Dihydropyrimidine compound and preparation method and use thereof
    Patent number: 11166954
    Abstract: The present invention relates to a method for prophylactically treating or treating a viral disease, comprising administering to a subject in need thereof a dihydropyrimidine compound, and the viral diseases include, but are not limited to, Hepatitis A, Hepatitis B, Hepatitis C, influenza, herpes and acquired immunodeficiency syndrome (AIDS).
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: November 9, 2021
    Assignee: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Shuai Song, Jiaqiang Cai, Qiang Tian, Hong Zeng, Hongmei Song, Hanwen Deng, Zujian Tang, Xiaofan Duan, Rongrong Long, Yao Liu, Lichun Wang, Jingyi Wang
  • DIHYDROPYRIMIDINE COMPOUND AND PREPARATION METHOD AND USE THEREOF
    Publication number: 20200253971
    Abstract: The present invention relates to a method for prophylactically treating or treating a viral disease, comprising administering to a subject in need thereof a dihydropyrimidine compound, and the viral diseases include, but are not limited to, Hepatitis A, Hepatitis B, Hepatitis C, influenza, herpes and acquired immunodeficiency syndrome (AIDS).
    Type: Application
    Filed: April 27, 2020
    Publication date: August 13, 2020
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Shuai Song, Jiaqiang Cai, Qiang Tian, Hong Zeng, Hongmei Song, Hanwen Deng, Zujian Tang, Xiaofan Duan, Rongrong Long, Yao Liu, Lichun Wang, Jingyi Wang
  • Dihydropyrimidine compound and preparation method and use thereof
    Patent number: 10696669
    Abstract: The present invention relates to a dihydropyrimidine compound having an antiviral activity, a pharmaceutical composition comprising same, a preparation method therefor and the uses thereof in the prevention or treatment of viral diseases including, but not limited to, Hepatitis A, Hepatitis B, Hepatitis C, influenza, herpes and acquired immunodeficiency syndrome (AIDS).
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: June 30, 2020
    Assignee: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICALS CO., LTD.
    Inventors: Shuai Song, Jiaqiang Cai, Qiang Tian, Hong Zeng, Hongmei Song, Hanwen Deng, Zujian Tang, Xiaofan Duan, Rongrong Long, Yao Liu, Lichun Wang, Jingyi Wang
  • CYTOTOXIN AND CONJUGATE, USES OF SAME AND PREPARATION METHOD THEREFOR
    Publication number: 20200179529
    Abstract: Provided is a method for modifying a chimeric antigen receptor-modified T cell (CAR-T cell). The method comprises expressing an SCFV-CDS TM-4-1BB-CD3? molecule in a T cell. The CAR-T cell prepared using the method can specifically recognize and bind to a tumor cell with elevated expression of a ROBO1 protein, and can be used to prevent and treat a corresponding tumor-related disease.
    Type: Application
    Filed: April 12, 2018
    Publication date: June 11, 2020
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Jiaqiang CAI, Tongtong XUE, Shuai SONG, Jing WANG, Qiang TIAN, Liang XIAO, Hanwen DENG, Liping LIU, Zujian TANG, Hong ZENG, Rongrong LONG, Hongmei SONG, Qiang ZHANG, Guoqing ZHONG, Dengnian LIU, Haitao HUANG, Ruibin HU, Lichun WANG, Jingyi WANG
  • DIHYDROPYRIMIDINE COMPOUND AND PREPARATION METHOD AND USE THEREOF
    Publication number: 20190225603
    Abstract: The present invention relates to a dihydropyrimidine compound having an antiviral activity, a pharmaceutical composition comprising same, a preparation method therefor and the uses thereof in the prevention or treatment of viral diseases including, but not limited to, Hepatitis A, Hepatitis B, Hepatitis C, influenza, herpes and acquired immunodeficiency syndrome (AIDS).
    Type: Application
    Filed: November 9, 2017
    Publication date: July 25, 2019
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Shuai SONG, Jiaqiang CAI, Qiang TIAN, Hong ZENG, Hongmei SONG, Hanwen DENG, Zujian TANG, XIAOFAN DUAN, Rongrong LONG, Yao LIU, Lichun WANG, Jingyi WANG